Skip to main content
. 2019 Feb 26;17(5):4710–4716. doi: 10.3892/ol.2019.10075

Table I.

Cetuximab sensitivities and culture of six CRC cell lines.

Cell line Cetuximab sensitivity Growth inhibition relative to control (%) Culture medium
CACO2 Resistant 0 EMEM + 1% NEAA + 10% FBS
COLO320DM Resistant 0 RPMI1640 + 10% FBS
C10 Partially resistant 5.9 IMDM + 10% FBS
HT55 Partially resistant 21.3 EMEM + 1% NEAA + 20% FBS
SW48 Sensitive 69.1 L15 + 10% FBS
C99 Sensitive 96.8 IMDM + 10% FBS

CRC, colorectal cancer; NEAA, non-essential amino acids; FBS, fetal bovine serum.